Adil Pelister: “Turkey can be the Star of the Pharmaceutical Sector”
Application of The Turkish Medicines and Medical Devices Agency (TITCK) of Republic of Turkey Ministry of Health for full membership of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), which brings together the medicines regulatory authorities and pharmaceutical industry around the world, was approved by a unanimous vote in the council meeting dated May 27. Adil Pelister, Chairman of Istanbul Chemicals and Chemical Products Exporters’ Association (IKMIB) made a written assessment on the subject.
Pelister declared as follows, “Compliance with Turkey’s full membership to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), which had the initial objective of coordinating the regulatory activities of the European, Japanese and United States regulatory bodies in consultation with the pharmaceutical trade associations from these regions, to discuss and agree the scientific aspects arising from product registration, It has been registered that the activities carried out in the name of medicine in our country meet international standards. ICH is publishing drug regulations around the world to guarantee that drugs are effective, safe and of high quality. In this context, the fact that our country has a voice in drug development and production processes will not only give international reputation to our country, but will also accelerate the export of our Turkish pharmaceutical industry.
I sincerely congratulate everyone, including Dr. Fahrettin Koca, the Health Minister and Dr. Hakkı Gürsöz, Vice President of TITCK, for their struggle and helpful approach that our country showed during the pandemic process caused us to attract attention all over the world. I think that this proud development will have a positive impact on our international trade in the coming days.
Research and development studies for the vaccine to prevent the new coronavirus Covid-19 and the drug to be used in its treatment are still continuing in our country. Regardless of the country, there will be a huge development in the name of humanity. As IKMIB, we continue to work with all our strength in order for the Turkish pharmaceutical and medical sectors to sign important discoveries in our country on a global scale. I believe that Turkey will also star in this area.”